About
Chief Medical Officer at RDiscovery with over 30 years of clinical, research, and pharmaceutical industry experience, including 18 years at Pfizer, Merck, and Bristol Myers Squibb. Holds an MD and PhD from Jichi Medical University, an MBA, and an MPH from Johns Hopkins.
Experience
- Sanodyne TherapeuticsAdvisorcurrent2025 β present
- Remiges Ventures, Inc.Chief Medical Officercurrent2025 β present
- Remiges Ventures, Inc.Scientific Advisorcurrent2023 β present
- Imel Therapeutics, KKChief Medical Officercurrent2023 β presentTokyo, Japan
- Nassau Biopharma ConsultingFoundercurrent2021 β presentPrinceton, New Jersey, United States
- Institute for Healthcare Leadership/γγ«γΉγ±γ’γͺγΌγγΌγ·γγη η©ΆδΌPresident and Chairman of the Boardcurrent2021 β presentTokyo, Japan
- Institute for Healthcare Leadership/γγ«γΉγ±γ’γͺγΌγγΌγ·γγη η©ΆδΌBoard Member2009 β 2021Tokyo, Japan
- Luzsana BiotechnologyVP, Global Head of Clinical Science, Innovative Medicine (US/EU)2022Princeton, New Jersey, United States
- Jiangsu Hengrui Pharmaceuticals Co., Ltd.VP, Global Head of Clinical Science, Innovative Medicine (US/EU)2022United States
- Bristol Myers SquibbVice President, Head of FXI, Worldwide Medical Cardiovascular2020 β 2021Princeton, New Jersey, United States
- Bristol Myers SquibbWorld Wide Medical Lead-Cardiovascular2019 β 2020Princeton, New Jersey, United States
- Bristol Myers SquibbHead of Biomarkers and Early Assets, Worldwide Oncology Commercialization2018 β 2019Princeton, New Jersey, United States
- Bristol Myers SquibbHead of Medical and Development, Japan-Korea-Taiwan2015 β 2017Tokyo, Tokyo, Japan
- Bristol Myers SquibbVP, Japan Head of Medical Affairs and Pharmacovigilance2013 β 2015Tokyo, Tokyo, Japan
- MSDDirector, Business Innovation Group, Office of Strategy2012 β 2013Tokyo, Tokyo, Japan
- MSDAsia Pacific Regional Director, Medical Affairs, Cardiovascular/Atherosclerosis2011 β 2012Singapore
- MSDJapan Regional Director for Medical Affairs for Cardiovascular and Athelosclerosis2009 β 2011Tokyo, Tokyo, Japan
- Pfizer Japan Inc.Medical Director for Cardiovascular disease2005 β 2009Tokyo, Tokyo, Japan
- Pfizer Japan Inc.Japan/Asia Regional Medical Advisor for CV2008 β 2009Tokyo, Tokyo, Japan
- Stem Cell Institute, University of MinnesotaResearch Associate2002 β 2005Minneapolis, Minnesota, United States
- Department Of Biochemistry, Jichi Medical University School Of MedicineResearch Associate2002Tochigi, Japan
- Haga Red Cross HospitalStaff Doctor2000 β 2002Mooka, Tochigi, Japan
- National Health Insurance Nogami ClinicDirector1998 β 2000
- Department of Internal Medicine, Haga Red Cross HospitalChief Resident1995 β 1998Mooka, Tochigi, Japan
- Jichi Medical University Medical CenterResident1993 β 1995Minamikawachi, Tochigi, Japan
Skills & more
StrategyClinical Research25Internal Medicine17Pharmaceuticals1Cardiology9Pharmaceutical Industry28Corporate strategy development, Adjacency business ideation1Medicine12Diabetes7Clinical Trials33Medical Affairs29Product Launch7
+6 more
Integrated Evidence Generation PlanningPortfolio Commercialization StrategyBusiness DevelopmentDrug DevelopmentSituational LeadershipCultural SensitivityLanguages English Β· Japanese
- The Program on Negotiation β Harvard Law School
- Medical Practice License in Japan β Ministry of Health, Labour and Welfare
- Board certified member of Japanese Society of Internal Medicine β United Latino Students Association
From Hiroshi's professional profile.
Colleagues at RDiscovery
Atsushi Uno
Senior Researcher at RDiscovery
Hans Keirstead
Chairman at RDiscovery
Kanako Amano
Researcher at RDiscovery
Kazuhiko Nonomura
Partner at Remiges Ventures, Inc.
Kyoko Matsumoto
Senior Associate at Remiges Ventures, Inc.
Lina Li
Venture Partner at RDiscovery
Masako Shimazaki
Researcher at RDiscovery
Satoshi Gojo
Scientific Advisor at RDiscovery
Frequently asked questions
- Who is Hiroshi Tamada?
- Chief Medical Officer at RDiscovery with over 30 years of clinical, research, and pharmaceutical industry experience, including 18 years at Pfizer, Merck, and Bristol Myers Squibb. Holds an MD and PhD from Jichi Medical University, an MBA, and an MPH from Johns Hopkins.
- Where does Hiroshi Tamada work?
- Hiroshi Tamada is Chief Medical Officer at RDiscovery.
- Where did Hiroshi Tamada go to school?
- Hiroshi Tamada studied at The Johns Hopkins University (Master of Public Health (MPH), Public Health); Kenichi Ohmae Graduate School of Business (MBA, Business Administration); Hibernia College (MSc, Pharmaceutical Medicine).
Same school
Also attended The Johns Hopkins University261
Wes NicholsPartner at March Capital PartnersDemi ObayomiPrincipal at Sapphire VenturesJun JeonInvestor at Khosla VenturesNicole FraenkelInvestor at Khosla VenturesElena VibochManaging Director at General CatalystScott RubinVenture Partner at Lux Capital
+ 255 more
Also attended Hibernia College1
Shared employers
Also worked at Jiangsu Hengrui Pharmaceuticals Co., Ltd.1
Also worked at Bristol Myers Squibb51
Dan LynchInvestor at GV (Google Ventures)Scott BillerInvestor at GV (Google Ventures)Avantika DaingFounding Partner at Plum Alley InvestmentsJake BauerVenture Partner at ARCH Venture PartnersBeth SeidenbergFounding Managing Director at Westlake Village BioPartnersAdam ZongEntrepreneur-In-Residence at The Innovation Space
.png)
+ 45 more
Also worked at MSD8
Ramy RiadPresident, Plasma-Derived Therapies Business Unit at Takeda VenturesSofia HasselbergInvestment Director at Bonnier CapitalKhatereh AhmadiVenture Partner at XGEN VentureMichelle HohmannSenior HR Manager & Recruiter at Apollo Health VenturesMirjam Mol-ArtsAdvisory Committee member at Curie CapitalPriya AgrawalMSD at i3 β Investing in Innovation Africa
/https%3A%2F%2Fbonniercapital.se%2Fwp-content%2Fuploads%2F2023%2F02%2FSofia-3.jpg)
+ 2 more
Also worked at MSD106
Anika GuptaInvestor at GV (Google Ventures)Sam BlackmanEntrepreneur in Residence at GV (Google Ventures)Catherine Pearce, DHSc, MBAAdvisor at CincyTechDavid MollerInvestor at Third Rock VenturesAlan EzekowitzInvestor at Third Rock VenturesAndrea van ElsasInvestor at Third Rock Ventures
+ 100 more